The goal of the NHLBI Progenitor Cell Biology Consortium (PCBC) is to identify and characterize progenitor cell lineages, to direct the differentiation of stem and progenitor cells to desired cell fates, and to develop new strategies to address the unique challenges presented by the transplantation of these cells.
4th Annual PCBC Meeting: Call for Abstracts
We are soliciting abstracts for presentation at the 4th Annual NHLBI Progenitor Cell Biology Consortium (PCBC) meeting to be held in Dallas, TX, September 13-14, 2012.
All PCBC investigators and affiliated post-doctoral fellows and graduate students in the field of heart, lung
Generating Targeted Gene Insertion & Reporter Gene of iPSCs
NHLBI Funding Opportunity Announcement
1) Funding Opportunity Announcement Number: NHLBI-CSB-(AR)-2012-018A-CRS
The Core Center of Excellence in Hematology (CCEH) at the Fred Hutchinson Cancer Research Center (FHCRC)
The Core Center of Excellence in Hematology (CCEH) was established in September 1999 with funding from NIDDK (http://cceh.fhcrc.org/).
2012 PCBC Skills Training Opportunities
The PCBC Skills Development Committee would like to share some exciting training opportunities with you.
Integrative Omics Data Analysis for Discovery in Lung Diseases (R01)
NHLBI Funding Opportunity Announcement
Funding Opportunity Announcement Number: PAR-12-155
Application Due Date(s): June 19, 2012; June 19, 2013; June 19, 2014
This FOA will ena
Armed Forces Institute of Regenerative Medicine - II (AFIRM II)
Funding Opportunity Announcement
Agency: Department of the Army –USAMRAA
Funding Opportunity Number: W81XWH-13-AFIRM-IIRP
Closing Date for Applications: July 11, 2012
Estim
Currently Funded PCBC Projects: Pilot and Ancillary/Collaborative Studies
The mission of the NHLBI Progenitor Cell Biology Consortium is to develop improved understanding of the biology of stem and progenitor cells, and to harness this knowledge for the diagnosis and treatment of heart, lung, and blood diseases.
Request for Information from NIH CRM – Defining Unmet Needs for Clinical Translation of Cell-Based Therapies
The Common Fund’s NIH Center for Regenerative Medicine (NIH CRM) seeks comments on persistent unmet needs that currently impede technical and scientific progress in translating advances in stem-and progenitor cell-based technologies to the clinic, and where NIH investment and/or coordination can help in overcoming these impediments.
Dr. Gary H. Gibbons - New Director of the NIH’s National Heart, Lung, and Blood Institute (NHLBI)
On April 5, 2012, Gary H. Gibbons, M.D., was named as the new director of the NIH’s National Heart, Lung, and Blood Institute (NHLBI).
Dr.
NHLBI Progenitor Cell Biology Consortium Administrative Coordinating Center